Nicholas Bell is a skilled professional in strategic operations, currently serving as the Director at CorMedix Therapeutics since 2025. Previously, they contributed to the innovative development at Johnson & Johnson Vision in 2019 and managed research operations at the University of Kentucky from 2016 to 2017. Nicholas’s early experience includes work as a Laboratory Technician at Biosphere 2 in 2013, where they advanced green roof research. They hold a Bachelor of Science in Biology from the University of Arizona and an MBA from The Ohio State University Fisher College of Business.
This person is not in the org chart
This person is not in any teams
This person is not in any offices